Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 open-label study of AL101 in Notch-activated adenoid cystic carcinoma
MOH_2020-01-27_008656Phase 2Active, not recruiting
- Sponsor
- Ayala Pharmaceuticals, Inc.
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of osugacestat in adenoid cystic carcinoma (ACC), sponsored by Ayala Pharmaceuticals, Inc. Started Sep 2019; status: active, not recruiting.
02
Drugs
osugacestat
03
Conditions
adenoid cystic carcinoma (ACC)
Beyond the preview
Go deeper on MOH_2020-01-27_008656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-01-27_008656.